Search Results (784)

Drug discovery is a complex and multi-stage process that requires advanced analytical technologies capable of accelerating preclinical evaluation and improving the precision of therapeutic design. The combination of fluorescence and magnetic resonance imaging (MRI) within multimodal imaging plays an increasingly important role in modern pharmacokinetics, integrating the high molecular sensitivity of fluorescence with the non-invasive anatomical visualization offered by MRI. Fluorescence enables real-time monitoring of cellular processes, including drug–target interactions and molecular dynamics, whereas MRI provides detailed structural information on tissues without exposure to ionizing radiation. Hybrid probes—such as superparamagnetic iron oxide nanoparticles (SPIONs) functionalized with near-infrared (NIR) fluorophores or gadolinium-based complexes linked to optical dyes—enable simultaneous acquisition of molecular and anatomical data in a single examination. These multimodal systems are being explored in oncology, neurology, and cardiology, where they support improved visualization of tumor biology, amyloid pathology, and inflammatory processes in vascular disease. Although multimodal imaging shows great promise for enhancing pharmacokinetic and pharmacodynamic studies, several challenges remain, including the potential toxicity of heavy-metal-based contrast agents, limited tissue penetration of fluorescence signals, probe stability in vivo, and the complexity and cost of synthesis. Advances in nanotechnology, particularly biodegradable carriers and manganese-based MRI contrasts, together with the integration of artificial intelligence algorithms, are helping to address these limitations. In the future, fluorescence–MRI hybrid imaging may become an important tool in personalized medicine, supporting more precise therapy planning and reducing the likelihood of clinical failure. Full article

Alkaline treatment in 0.2 and 0.4 M NaOH solutions successfully generated controlled mesoporosity into ZSM-5 (Zeolite Socony Mobil-5) zeolite, resulting in average mesopore diameters of approximately 15 and 25 nm, respectively, while preserving the crystalline structure of the zeolite framework. Parent ZSM-5 and its mesoporous derivatives obtained by desilication were used to prepare (Fe species)@(zeolite matrix) composites. The synthesis was carried out by co-precipitating Fe²⁺/Fe³⁺ ions onto both parent and desilicated ZSM-5 matrices under oxygen-free conditions. Comprehensive characterization by X-ray diffraction, scanning electron microscopy, N₂ adsorption, vibrating-sample magnetometry, ⁵⁷Fe Mössbauer spectroscopy, and diffuse reflectance UV–Vis spectroscopy revealed that the degree of introduced mesoporosity dramatically influences the size, dispersion, phase composition, and oxidation state of the iron-containing nanospecies. On purely microporous ZSM-5, relatively large (~15 nm) partially oxidized magnetite nanoparticles are formed predominantly on the external surface, exhibiting superparamagnetism at room temperature (Mₛ = 11 emu/g) and a band gap of 2.12 eV. Increasing mesoporosity leads to progressively smaller and more highly dispersed iron(III) oxo/hydroxo clusters with significantly lower blocking temperatures and reduced magnetization (down to 0.7 emu/g for Fe@ZSM-5_0.4). All composites display strong visible-light absorption confirming their potential as magnetically separable visible-light-driven photocatalysts for environmental remediation. Full article

Developing precise tumor-targeting delivery systems while minimizing off-target toxicity continues to pose significant challenges in medicine application. The integration of two different functional materials has emerged as a promising strategy in current biomedical research. Herein, a hybrid nanocomposite consisting of Fe₃O₄ and ZnO was synthesized via a simple approach and employed as a nanoscale drug delivery system to explore the loading capacity and stimuli-responsive release characteristics of the anticancer agent doxorubicin (DOX). Results show that the synthesized nanoparticles (NPs) exhibit a multi-scale nanostructure consisting of the spindle-like ZnO nanorods with a mean length of 280 nm, on which the Fe₃O₄ NPs with a diameter of around 16 nm are uniformly dispersed. The ZnO@Fe₃O₄ NPs possess superparamagnetic behavior and a fast response to the external magnet and demonstrate exceptional near-infrared (NIR) photothermal conversion efficiency. In drug release studies, the ZnO@Fe₃O₄ NPs achieve the controlled DOX release in the simulated acidic tumor microenvironment as well as NIR laser irradiation. Further, the ZnO@Fe₃O₄-DOX composites significantly suppress the viability of human cervical cancer cells (HeLa) upon laser activation. These findings suggest that ZnO@Fe₃O₄ NPs are promising candidates for combined photothermal therapy, magnetic-targeted drug delivery, and stimuli-responsive controlled release applications. Full article

Superparamagnetic iron oxide nanoparticles (SPIONs) are commonly produced through wet-chemical methods that require high temperature and pressure and involve multiple synthesis steps. Our research group has developed an innovative, sustainable, and patented one-step aqueous synthesis operating at ambient temperature and pressure, enabling the direct production of SPIONs in suspension. In this work, we investigated the extension of this method to obtain polymer-coated SPIONs for biomedical imaging applications. Two water-soluble and biocompatible polymers—poly(ethylene glycol) (PEG) and poly(vinyl alcohol) (PVA)—were selected and prepared into twelve samples varying in polymer concentration and iron precursor molarity. Each formulation was characterized and compared to bare SPIONs synthesized with the same approach using X-ray diffraction (XRD), Fourier transform infrared spectroscopy (FT-IR), transmission electron microscopy (TEM), and alternating gradient magnetometry (AGM). The results confirm that the one-step method yields polymer-coated nanoparticles with a cubic spinel magnetite core. PEG produced spherical, monodisperse particles (10–30 nm) exhibiting superparamagnetic behavior but lower magnetization values (1–5 emu/g). In contrast, PVA-coated nanoparticles showed a morphology dependent on polymer concentration and reagent molarity, while maintaining an average size of ~10 nm and superparamagnetic behavior, with magnetization comparable to bare SPIONs (25–50 emu/g). A preliminary MRI evaluation of a selected PVA-coated sample revealed relaxivity values of r₁ = 0.12 mM⁻¹ s⁻¹ and r₂ = 6.44 mM⁻¹ s⁻¹, supporting the potential of this synthesis route for imaging-oriented nanomaterials. Full article

Breast cancer is one of the most prevalent malignant tumors worldwide, with the highest incidence and mortality among women. Early precise diagnosis and the development of efficient treatment regimens remain major clinical challenges. Harnessing the programmable size, surface chemistry, and tumor microenvironment (TME) responsiveness of nanomaterials, there is tremendous potential for their applications in breast cancer diagnosis and therapy. In the diagnostic arena, nanomaterials serve as core components of novel contrast agents (e.g., gold nanorods, quantum dots, superparamagnetic iron oxide nanoparticles) and biosensing platforms, substantially enhancing the sensitivity and specificity of molecular imaging modalities—such as magnetic resonance imaging (MRI), computed tomography (CT), and fluorescence imaging (FLI)—and enabling high-sensitivity detection of circulating tumor cells and tumor-derived exosomes, among various liquid biopsy biomarkers. In therapy, nanoscale carriers (e.g., liposomes, polymeric micelles) improve tumor targeting and accumulation efficiency through passive and active targeting strategies, thereby augmenting anticancer efficacy while effectively reducing systemic toxicity. Furthermore, nanotechnology has spurred the rapid advancement of emerging modalities, including photothermal therapy (PTT), photodynamic therapy (PDT), and immunotherapy. Notably, the construction of theranostic platforms that integrate diagnostic and therapeutic units within a single nanosystem enables in vivo, real-time visualization of drug delivery, treatment monitoring, and therapeutic response feedback, providing a powerful toolkit for advancing breast cancer toward personalized, precision medicine. Despite challenges that remain before clinical translation—such as biocompatibility, scalable manufacturing, and standardized evaluation—nanomaterials are undoubtedly reshaping the paradigm of breast cancer diagnosis and treatment. Full article

Multimodal nanocomposites that combine optical and magnetic functionalities are of great interest for applications such as imaging and temperature sensing. Ternary CuInS₂ (CIS)-based quantum dots (QDs) offer low toxicity, strong near-infrared (NIR) emission, and high photostability, making them promising for optical nanothermometry and imaging. In this study, CIS QDs were synthesized using an aqueous cysteine-mediated approach. Manganese ferrite (MnFe₂O₄) nanoparticles were prepared as the magnetic component due to their non-toxicity and superparamagnetic properties. To integrate both functionalities, QDs and magnetic nanoparticles (MNPs) were encapsulated in silica and then combined to form multimodal CIS/MnFe₂O₄/SiO₂ nanocomposites. The structure and morphology of the materials were characterized by TEM and XRD, while their optical properties were examined using UV–Vis, photoluminescence (PL) spectroscopy. This design ensured optical isolation, preventing fluorescence quenching while maintaining colloidal stability. The obtained composites exhibited PL in the NIR region and a thermosensitivity of 2.04%/°C. TEM analysis confirmed uniform silica shell formation and successful integration of both components within the composite. The materials also retained the superparamagnetic behavior of MnFe₂O₄, making them suitable for combined optical and magnetic functionalities. These results demonstrate the potential of CIS/MnFe₂O₄/SiO₂ nanocomposites as multifunctional platforms for optical imaging, temperature monitoring, and magnetically modulated effects. Full article

Glioblastoma multiforme (GBM) is a highly aggressive primary brain tumour with limited treatment options and a poor prognosis. Therapeutic failure is driven by multiple barriers, including the blood–brain barrier (BBB), the tumour microenvironment (TME), and intratumoural heterogeneity. Conventional delivery systems often fail to achieve sufficient drug accumulation or controlled release within the tumour. In this review, we outline a theoretical framework for the design of ligand-functionalised magnetic lipid nanoparticles (MF-R-LNs), a multifunctional nanoplatform that integrates active targeting, stimuli-responsive drug release, and external magnetic-field control. The proposed MF-R-LNs incorporate superparamagnetic iron oxide nanoparticles (SPIONs) for magnetic guidance and hyperthermia; polyethylene glycol (PEG) for extended circulation; and surface ligands such as peptides, antibodies, or aptamers to target GBM-specific receptors including epidermal growth factor receptor (EGFR), Interleukin-13 receptor alpha-2 (IL-13Rα2), and integrins. Triggered release mechanisms such as pH-sensitive lipids, redox cleavable linkers, and enzyme-responsive coatings enable selective drug release within the TME. Magnetic hyperthermia serves as both a therapeutic modality and a remote trigger to enhance release and tumour penetration. This modular design offers a theoretically robust strategy to overcome the key physiological and therapeutic barriers in GBM. We discuss the rationale behind each design feature, explore potential synergies, and highlight translational challenges such as tumour heterogeneity, manufacturing complexity, and safety concerns. Despite encouraging preclinical evidence, clinical translation faces substantial hurdles, notably patient-specific heterogeneity and scalable GMP manufacturing/characterisation of multi-component nanoplatforms. While preclinical validation remains necessary, this framework may inform future efforts to develop spatiotemporally controlled, multifunctional therapeutics for glioblastoma. This manuscript is a conceptual framework review that synthesises current strategies into actionable guidance for designing and reporting MF-R-LNs for GBM. Full article

Small interfering RNAs (siRNAs) provide strong therapeutic potential due to their efficient gene-silencing properties; however, their instability limits clinical application. Nanoparticle carriers may overcome this problem; in particular, magnetic nanoparticles show great promise as they can be directed to the target sites by external magnetic fields, thus improving delivery efficiency and reducing off-target effects. In addition, magnetic nanoparticles offer a novel nanoplatform for theranostic applications, integrating siRNA delivery with magnetic resonance imaging and magnetic hyperthermia for synergistic diagnostic and therapeutic advantages. The present work reports the development of a novel platform based on biomimetic magnetic nanoparticles made of Fe(II)/Fe(III)-doped apatite (FeHA) nucleated and grown in the presence of cherry and pomegranate leaf extracts to enhance the colloidal stability and make it suitable for nucleic acid delivery under the guidance of magnetic fields. This approach allowed the obtention of FeHA suspension with increased negative zeta potential leading to very good stability. In addition, the functionalization with natural extracts conferred antioxidant properties also favoring the maintenance of the Fe(III)/Fe(II) ratio in the apatitic structure, inducing the superparamagnetic properties. To evaluate the delivery capability of the system, a model GAPDH-targeting siRNA molecule was employed. Its interaction with the nanoplatform was characterized by assessing loading capacity and release kinetics, which were further interpreted using mathematical modeling to elucidate the underlying release mechanisms. Full article

Superparamagnetic iron oxide nanoparticles (SPIONs) have shown promise across a wide range of biomedical applications, including targeted drug delivery, magnetic hyperthermia, magnetic resonance imaging, and regenerative medicine. In the context of local tumor therapy (Magnetic Drug Targeting, MDT) SPIONs can be functionalized with chemotherapeutic agents and accumulated at tumor sites using an externally applied magnetic field. To achieve effective drug accumulation and therapeutic efficacy, precise positioning of the accumulation magnet relative to the tumor is essential. To address this need, we propose a dual-modality ultrasound imaging approach combining magnetomotive ultrasound (MMUS) and passive cavitation mapping (PCM). MMUS detects magnetically induced displacements to localize SPIONs embedded in elastic tissue, while PCM monitors cavitation emissions from circulating SPIONs under focused ultrasound exposure. In addition to detection, PCM has the potential to enable feedback-based control of cavitation exposure, allowing cavitation parameters to be kept within a safe regime. The dual imaging modality approach was validated using standard phantoms and a complex carotid bifurcation tumor flow phantom fabricated via 3D printing. Experimental results demonstrate the first coordinated spatiotemporal imaging of MMUS and PCM within the same anatomical model, resolving the key bottleneck of SPIONs monitoring in blood vessels/tissue. This demonstrates the strong potential of complementary MMUS and PCM imaging for monitoring in preclinical and clinical MDT settings. Full article

Background: Radioactive colloids are considered the standard of care for sentinel lymph node (SLN) detection. An alternative detection method using superparamagnetic iron oxide (SPIO) nanoparticles is well documented in breast cancer but poorly studied for gynecological tumors, including vulvar cancer (VC). Objective: Our aim was to evaluate the feasibility, accuracy, and safety of SPIO nanoparticles for SLN mapping in patients with VC as a stand-alone technique compared with the combination of two methods: the standard of care using a radioactive isotope (technetium-99; Tc-99) and SPIO as a new tracer. Methods: We conducted a prospective and observational study of SLN mapping in patients with stage IB VC and tumor size ≤ 4 cm. We calculated detection and malignancy rates per patient and per groin in both study groups. During the 36-month follow-up, the groin recurrence rate was estimated for positive and negative SLNs. Kaplan–Meyer curves were used to analyze the probability of survival, depending on disease-free survival. Results: A total of 110 groins assessed by SLN in 60 patients included in this study were analyzed (70 groins from 40 patients in the group with a single tracer and 40 groins from 20 patients in the group of combined tracers). At least one sentinel lymph node was detected in every patient while the bilateral detection rate was 92.3% for the SPIO group and 88.2% for the Tc-99 and SPIO group. The groin detection rate was 94.3% and 90%, respectively. SLN mapping failure was similar in both groups (2.8% and 2.5%, respectively). During a 3-year follow-up, the isolated groin recurrence rate was 2.1% for negative groins and for disease-free survival it was 28.9 months in the combined tracer group versus 32.8 months in the SPIO group. The Kaplan–Meyer curves showed the increased probability of survival for the SPIO group (87.5%); however, it was insignificant. Conclusions: SLN mapping using the SPIO technique in patients with VC is non-inferior to the combined SPIO and Tc-99 method. Full article

Magnetic Particle Imaging (MPI) is a new type of tracer-based imaging that has great spatial and temporal resolution, does not require ionizing radiation, and can see deep into tissues by directly measuring the nonlinear magnetization response of superparamagnetic iron oxide nanoparticles (SPIONs). Unlike Magnetic Resonance Imaging (MRI) or Computed Tomography (CT), MPI has very high contrast and quantitative accuracy, which makes it perfect for use in dynamic cardiovascular applications. This study presents a full picture of the most recent changes in cardiac MPI, such as the physics behind Field-Free Point (FFP) and Field-Free Line (FFL) encoding, new ideas for tracer design, and important steps in the evolution of scanner hardware. We discuss the clinical relevance of cardiac MPI in visualizing myocardial perfusion, quantifying blood flow, and guiding real-time interventions. A hybrid imaging workflow, which improves anatomical detail and functional assessment, is utilized to explore the integration of MPI with complementary modalities, particularly MRI. By consolidating recent preclinical breakthroughs and highlighting the roadmap toward human-scale implementation, this article underscores the transformative potential of MPI in cardiac diagnostics and image-guided therapy. Full article

Electromagnetic heating (EMH) using microwaves has emerged as a promising enhanced oil recovery (EOR) technique, particularly for heavy crude oils where conventional thermal methods encounter technical and environmental challenges. However, its large-scale implementation remains limited due to incomplete understanding of its energy transfer mechanisms. This study proposes an experimental–numerical approach integrating magnetic graphene oxide nanoparticles (Fe₃O₄@GO) with microwave heating to enhance energy absorption near the wellbore. The nanomaterial was synthesized via a modified Hummer’s method followed by in situ magnetite precipitation and studied through multiple material characterization techniques showing uniform 80 nm particles with superparamagnetic behavior—ideal for EMH applications. Nine experiments were conducted on sand–heavy-oil–water systems with nanoparticle concentrations up to 500 ppm using a laboratory microwave heating prototype. A simulation model was then developed in CMG-STARS for history matching to estimate energy absorption as a function of saturation and nanoparticle concentration. Experiments reached temperatures up to 240 °C, with 653 MJ of effective heat transferred to the target zone over 55 h, as estimated from the input heat required in the simulator for history matching. The results confirm that magnetic graphene oxide nanoparticles enhance thermal efficiency and heat distribution in microwave-assisted EOR. Full article

Magnetic Particle Imaging (MPI) is a cutting-edge noninvasive imaging technique that offers high sensitivity, quantitative accuracy, and operates without the need for ionizing radiation compared to other imaging techniques. Utilizing superparamagnetic iron oxide nanoparticles (SPIONs) as tracers, MPI enables direct and precise visualization of target sites with no limitation on imaging depth. Unlike magnetic resonance imaging (MRI), which relies on uniform magnetic fields to produce anatomical images, MPI enables direct, background-free visualization and quantification of SPIONS within living organisms. This article provides an in-depth overview of MPI’s applications in tracking tumor development and supporting cancer therapy. The distinct physical principles that underpin MPI, including its ability to produce high-contrast images devoid of background tissue interference, facilitating accurate tumor identification and real-time monitoring of treatment outcomes, are outlined. The review outlines MPI’s advantages over conventional imaging techniques in terms of sensitivity and resolution, and examines its capabilities in visualizing tumor vasculature, tracking cellular movement, evaluating inflammation, and conducting magnetic hyperthermia treatments. Recent progress in tracer optimization and magnetic navigation has expanded MPI’s potential for targeted drug delivery, along with deep machine learning procedures for MPI applications. Additionally, considerations around safety and the feasibility of clinical implementation are also discussed in the present review. Overall, MPI is positioned as a promising tool in advancing cancer diagnostics, personalized therapy assessment, and noninvasive treatment strategies. Full article

Gene editing technologies such as CRISPR/Cas9 have revolutionized functional genomics, yet their application in marine fish cell lines remains limited by inefficient delivery. This study compares three delivery strategies—electroporation, lipid nanoparticles (LNPs), and magnetofection using gelatin-coated superparamagnetic iron oxide nanoparticles (SPIONs)—for CRISPR/Cas9-mediated editing of the ifi27l2a gene in DLB-1 and SaB-1 cell lines. We evaluated transfection and editing efficiency, intracellular Cas9 localization, and genomic stability of the target locus. Electroporation achieved up to 95% editing in SaB-1 under optimized conditions, but only 30% in DLB-1, which exhibited locus-specific genomic rearrangements. Diversa LNPs enabled intracellular delivery and moderate editing (~25%) in DLB-1 but yielded only minimal editing in SaB-1, while SPION-based magnetofection resulted in efficient uptake but no detectable editing, highlighting post-entry barriers. Confocal imaging and fluorescence correlation spectroscopy suggested that nuclear localization and Cas9 aggregation may influence editing success, highlighting the importance of intracellular trafficking in CRISPR/Cas9 delivery. Our findings demonstrate that CRISPR/Cas9 delivery efficiency is cell line-dependent and governed by intracellular trafficking and genomic integrity. These insights provide a practical framework for optimizing gene editing in marine teleosts, advancing both basic research and selective breeding in aquaculture. Full article

Superparamagnetic iron oxide nanoparticles (SPIONs) with sizes below 10 nm are biocompatible and non-toxic, making them promising for biomedical applications. To prevent their agglomeration and enhance their functionality, the nanoparticles were coated with citric acid (CA), which modifies the surface charge, improves dispersion stability, and facilitates biomedical use. In this work, a modular flow-through microreactor system was employed to synthesize and coat the nanoparticles in a single, continuous two-step process. The system enables precise control over temperature and mixing, ensuring uniform reaction conditions and minimizing hot spots. The synthesized Fe₃O₄ nanoparticles exhibited an average crystallite size of ~5 nm (XRD) and particle sizes of 4–6 nm (TEM). FTIR analysis confirmed the successful surface functionalization with CA, while TGA indicated a coating mass fraction of approximately 4–20 wt%, increasing with higher CA concentration. Zeta potential measurements revealed strong colloidal stability, with values around −35 mV at pH 6.5. Among the tested CA concentrations, the sample with a molar ratio of Fe₃O₄:CA = 1:0.25 exhibited the most favorable properties, including narrow size distribution and improved dispersion stability. These findings demonstrate that the continuous modular flow approach enables the reproducible synthesis of highly stable, sub-10 nm CA-coated SPIONs, offering promising potential for biomedical applications, particularly as magnetic resonance imaging (MRI) contrast agents. Full article